Creative Medical Technology Holdings, Inc. (CELZ)
0.60
-0.01
(-0.98%)
USD |
NASDAQ |
Nov 06, 10:00
Creative Medical Technology Holdings Market Cap : 3.895M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 3.934M |
| November 04, 2026 | 4.232M |
| November 03, 2026 | 4.372M |
| November 02, 2026 | 4.048M |
| October 30, 2026 | 4.252M |
| October 29, 2026 | 4.404M |
| October 28, 2026 | 4.674M |
| October 27, 2026 | 4.481M |
| October 26, 2026 | 4.622M |
| October 23, 2026 | 4.804M |
| October 22, 2026 | 5.025M |
| October 21, 2026 | 4.820M |
| October 20, 2026 | 4.900M |
| October 19, 2026 | 4.698M |
| October 16, 2026 | 4.811M |
| October 15, 2026 | 5.309M |
| October 14, 2026 | 5.014M |
| October 13, 2026 | 5.323M |
| October 12, 2026 | 5.460M |
| October 09, 2026 | 5.444M |
| October 08, 2026 | 5.586M |
| October 07, 2026 | 5.771M |
| October 06, 2026 | 5.845M |
| October 05, 2026 | 5.973M |
| October 02, 2026 | 6.144M |
| Date | Value |
|---|---|
| October 01, 2026 | 6.114M |
| September 30, 2026 | 6.067M |
| September 29, 2026 | 6.266M |
| September 28, 2026 | 6.557M |
| September 25, 2026 | 6.687M |
| September 24, 2026 | 6.297M |
| September 23, 2026 | 6.322M |
| September 22, 2026 | 6.102M |
| September 21, 2026 | 6.524M |
| September 18, 2026 | 6.271M |
| September 17, 2026 | 5.697M |
| September 16, 2026 | 5.336M |
| September 15, 2026 | 5.745M |
| September 14, 2026 | 5.699M |
| September 11, 2026 | 6.236M |
| September 10, 2026 | 6.169M |
| September 09, 2026 | 6.752M |
| September 08, 2026 | 7.011M |
| September 04, 2026 | 7.206M |
| September 03, 2026 | 6.882M |
| September 02, 2026 | 7.336M |
| September 01, 2026 | 7.141M |
| August 31, 2026 | 7.336M |
| August 28, 2026 | 7.401M |
| August 27, 2026 | 7.401M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.596B |
| Alnylam Pharmaceuticals, Inc. | 21.01B |
| Anika Therapeutics, Inc. | 227.51M |
| Savara, Inc. | 934.57M |
| Vericel Corp. | 2.616B |
Market Cap Related Metrics
| PS Ratio | 684.03 |
| Price to Book Value | 0.4500 |
| Price | 0.60 |
| Earnings Yield | -296.3% |